Cargando…
Effects of Carbidopa Premedication on (18)F-FDOPA PET Imaging of Glioma: A Multiparametric Analysis
SIMPLE SUMMARY: (18)F-FDOPA PET imaging is routinely used and recommended to assess gliomas. Carbidopa is a peripheral enzyme inhibitor. Carbidopa premedication increases the radiotracer uptake on static images. None of the evidence-based data available to date recommends carbidopa premedication. Ou...
Autores principales: | Bros, Marie, Zaragori, Timothée, Rech, Fabien, Blonski, Marie, Hossu, Gabriela, Taillandier, Luc, Marie, Pierre-Yves, Verger, Antoine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582429/ https://www.ncbi.nlm.nih.gov/pubmed/34771504 http://dx.doi.org/10.3390/cancers13215340 |
Ejemplares similares
-
Dynamic (18)F-FDopa PET Imaging for Newly Diagnosed Gliomas: Is a Semiquantitative Model Sufficient?
por: Zaragori, Timothée, et al.
Publicado: (2021) -
Implementing the Point Spread Function Deconvolution for Better Molecular Characterization of Newly Diagnosed Gliomas: A Dynamic (18)F-FDOPA PET Radiomics Study
por: Ahrari, Shamimeh, et al.
Publicado: (2022) -
Use of static and dynamic [(18)F]-F-DOPA PET parameters for detecting patients with glioma recurrence or progression
por: Zaragori, Timothée, et al.
Publicado: (2020) -
Adult Diffuse Low-Grade Gliomas: 35-Year Experience at the Nancy France Neurooncology Unit
por: Obara, Tiphaine, et al.
Publicado: (2020) -
Multi-tracer and multiparametric PET imaging to detect the IDH mutation in glioma: a preclinical translational in vitro, in vivo, and ex vivo study
por: Clément, Alexandra, et al.
Publicado: (2022)